April 28, 2026
Hikma Pharmaceuticals PLC and Cipla Ltd. have reached settlements with Pfizer Inc. in a case over the two defendants' efforts to create generic versions of the heart medication Vyndamax.
April 24, 2026
Pfizer and Israeli generic-drug maker Dexcel on Friday agreed to drop a case Pfizer brought to block Dexcel from creating a generic version of the heart medication Vyndamax.
April 21, 2026
Drugmaker Pfizer and an Israeli competitor that is seeking to create a generic version of a Pfizer heart medication said Tuesday they have reached an agreement to remove two asserted patents from a trial set to start next week.
January 26, 2024
An Israeli drugmaker trying to market a generic version of one of Pfizer's historically more expensive brands of heart medication has agreed to limit its legal fight with the U.S. pharmaceutical giant to whether Pfizer's patents covering the drug will hold up in Delaware federal court.